PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1402029
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1402029
Surrogacy Market Forecasts to 2030 - Global Analysis By Type, Age Group, Technology, End User and by Geography
According to Stratistics MRC, the Global Surrogacy Market is accounted for $210.34 million in 2023 and is expected to reach $362.82 million by 2030 growing at a CAGR of 8.1% during the forecast period. A surrogate woman bears and gives birth to a child on behalf of another person or couple in a reproductive arrangement known as surrogacy. When conventional conception is difficult or impossible due to medical conditions, this assisted reproductive technology is used. Moreover, the two main forms of surrogacy are gestational surrogacy, in which the surrogate carries an embryo fertilized by in vitro fertilization (IVF), usually using the genetic material of the intended parents or donors, and traditional surrogacy, in which the surrogate contributes her egg.
According to a report by the World Health Organization (WHO), one in four couples in developing nation's experiences infertility. Additionally, 60-80 million couples worldwide suffer from infertility each year, with 15-20 million (25%) residing in India alone.
Market Dynamics:
Driver:
Raising awareness and acceptance
Growing awareness campaigns and a more candid conversation about fertility issues in society are supporting surrogacy's growing acceptance as a legal and compassionate reproductive option. Additionally, advocacy groups, internet forums, and educational programs help dispel the stigmas surrounding surrogacy and create a more encouraging atmosphere for single people and couples dealing with infertility.
Restraint:
Limited number of surrogates available
The surrogacy market is significantly constrained by the lack of willing and suitable surrogates. The process of matching intended parents with surrogates can be delayed when appropriate candidates who fulfill both medical and psychological requirements are difficult to find. Furthermore, social stigmas, worries about potential health hazards, or the rigorous requirements of the surrogacy procedure could all contribute to this shortage.
Opportunity:
Technological progress in reproductive health
Significant opportunities exist for the surrogacy market as a result of ongoing technological advancements in reproductive medicine, such as advances in genetic testing, embryo screening, and artificial reproductive techniques. Moreover, for intended parents, surrogacy is becoming a more practical and cost-effective option thanks to increased success rates, improved embryo selection, and the development of more advanced fertility treatments.
Threat:
Regulation changes and legal uncertainties
Diverse legal frameworks for surrogacy across different jurisdictions present a serious risk to the surrogacy industry. Additionally, swift alterations in laws or legal ambiguities could pose difficulties for surrogacy organizations, intended parents, and surrogates, resulting in possible legal conflicts and complications that could hinder the orderly advancement of surrogacy agreements.
COVID-19 Impact:
The COVID-19 pandemic has had a major effect on the surrogacy market and brought difficulties and disturbances to the assisted reproductive sector. Travel restrictions and lockdowns brought on by the pandemic have hindered the international mobility of intended parents, surrogates, and healthcare providers participating in the surrogacy process. There has been a brief decrease in surrogacy procedures due to ongoing health concerns, clinic closures, and delays in fertility treatments. Furthermore, the pandemic's effects on the economy could have an impact on intended parents' ability to afford surrogacy services.
The Gestational Surrogacy segment is expected to be the largest during the forecast period
As the most common and favored method of assisted reproduction, gestational surrogacy commands the largest share of the market. When a person is used in a gestational surrogacy, their eggs and sperm from donors or the intended parents are used to create an embryo through in vitro fertilization (IVF). This approach provides more emotional and legal clarity by severing genetic ties between the surrogate and the child. Moreover, reproductive technology advancements have made gestational surrogacy more widely recognized as a more controlled and predictable process.
The Fertility Clinics segment is expected to have the highest CAGR during the forecast period
In the surrogacy market, the segment with the highest CAGR is fertility clinics. These specialist clinics, which provide a range of cutting-edge reproductive services, are essential in tackling the growing incidence of infertility. Fertility clinics offer thorough diagnostic evaluations, state-of-the-art assisted reproductive technologies (ART), including in vitro fertilization (IVF), and individualized treatment programs made to meet each patient's or couple's specific needs. Additionally, the demand for the services provided by fertility clinics has increased due to rising societal acceptance of ART and increased awareness of fertility issues.
Region with largest share:
In the global surrogacy market, North America holds the largest share. Because of its sophisticated healthcare system, high level of awareness, and large investments in reproductive technologies, this region-which includes the United States and Canada-dominates. The high demand for fertility services is partly due to the cultural acceptance of assisted reproductive technologies (ART) and the prevalence of infertility problems. Moreover, North America's status as a major player in the reproductive healthcare industry is further cemented by the region's concentration of top fertility clinics, research institutes, and technological developments in the field.
Region with highest CAGR:
In terms of the global market for surrogacy, the Asia-Pacific region has the highest CAGR. The demand for reproductive services in Asia-Pacific is driven by the rising prevalence of infertility as well as increased understanding and acceptance of assisted reproductive technologies (ART). The region's rapid growth is caused by a number of factors, including evolving lifestyles, postponing family planning, and improvements in reproductive health. Furthermore, expanding fertility treatments and better healthcare infrastructure in Asia-Pacific nations support the market's growth.
Key players in the market:
Some of the key players in Surrogacy market include Extraordinary Conceptions, Boston IVF, Growing Generations LLC, IVIRMA Global, Max Healthcare, New Hope Fertility Center, Bourn Hall International, Houston Fertility Center, Circle Surrogacy & Egg Donation, Nova Ivi Fertility, Ovation Fertility, Scanfert Clinic and Care Fertility Group.
Key Developments:
In November 2023, IVI RMA, one of the largest reproductive medicine groups in the world, has signed a definitive agreement to acquire the North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO, from healthcare group Fresenius. The strategic additions will grow IVI RMA to become a leading fertility group in North America and reinforce the company's commitment to providing evidence-based fertility solutions with the greatest chance of success to the greatest number of patients.
In October 2023, Boston IVF, a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo. This prestigious annual event, in New Orleans, Louisiana, from October 14-18, brought together global experts to share groundbreaking advancements in technology, treatments, and patient care in reproductive medicine.
Types Covered:
- Gestational Surrogacy
- Traditional Surrogacy
- Other Types
Age Groups Covered:
- Below 35 Years
- 35-37 Years
- 38-39 Years
- 40-42 Years
- 43-44 Years
- Over 44 Years
Technologies Covered:
- Intrauterine Insemination (IUI)
- In-vitro Fertilization (IVF)
- Other Technologies
End Users Covered:
- Hospitals
- Fertility Clinics
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Technology Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Surrogacy Market, By Type
- 5.1 Introduction
- 5.2 Gestational Surrogacy
- 5.3 Traditional Surrogacy
- 5.4 Other Types
6 Global Surrogacy Market, By Age Group
- 6.1 Introduction
- 6.2 Below 35 Years
- 6.3 35-37 Years
- 6.4 38-39 Years
- 6.5 40-42 Years
- 6.6 43-44 Years
- 6.7 Over 44 Years
7 Global Surrogacy Market, By Technology
- 7.1 Introduction
- 7.2 Intrauterine Insemination (IUI)
- 7.3 In-vitro Fertilization (IVF)
- 7.3.1 Classical/Standard IVF
- 7.3.2 Intracytoplasmic Sperm Injection (ICSI)
- 7.4 Other Technologies
8 Global Surrogacy Market, By End User
- 8.1 Introduction
- 8.2 Hospitals
- 8.3 Fertility Clinics
- 8.4 Other End Users
9 Global Surrogacy Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Extraordinary Conceptions
- 11.2 Boston IVF
- 11.3 Growing Generations LLC
- 11.4 IVIRMA Global
- 11.5 Max Healthcare
- 11.6 New Hope Fertility Center
- 11.7 Bourn Hall International
- 11.8 Houston Fertility Center
- 11.9 Circle Surrogacy & Egg Donation
- 11.10 Nova Ivi Fertility
- 11.11 Ovation Fertility
- 11.12 Scanfert Clinic
- 11.13 Care Fertility Group
List of Tables
- Table 1 Global Surrogacy Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Surrogacy Market Outlook, By Type (2021-2030) ($MN)
- Table 3 Global Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
- Table 4 Global Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
- Table 5 Global Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
- Table 6 Global Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
- Table 7 Global Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
- Table 8 Global Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
- Table 9 Global Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
- Table 10 Global Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
- Table 11 Global Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
- Table 12 Global Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
- Table 13 Global Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
- Table 14 Global Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
- Table 15 Global Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
- Table 16 Global Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
- Table 17 Global Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
- Table 18 Global Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 19 Global Surrogacy Market Outlook, By End User (2021-2030) ($MN)
- Table 20 Global Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 21 Global Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
- Table 22 Global Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 23 North America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
- Table 24 North America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
- Table 25 North America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
- Table 26 North America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
- Table 27 North America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
- Table 28 North America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
- Table 29 North America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
- Table 30 North America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
- Table 31 North America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
- Table 32 North America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
- Table 33 North America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
- Table 34 North America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
- Table 35 North America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
- Table 36 North America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
- Table 37 North America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
- Table 38 North America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
- Table 39 North America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
- Table 40 North America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 41 North America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
- Table 42 North America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 43 North America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
- Table 44 North America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 45 Europe Surrogacy Market Outlook, By Country (2021-2030) ($MN)
- Table 46 Europe Surrogacy Market Outlook, By Type (2021-2030) ($MN)
- Table 47 Europe Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
- Table 48 Europe Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
- Table 49 Europe Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
- Table 50 Europe Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
- Table 51 Europe Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
- Table 52 Europe Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
- Table 53 Europe Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
- Table 54 Europe Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
- Table 55 Europe Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
- Table 56 Europe Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
- Table 57 Europe Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
- Table 58 Europe Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
- Table 59 Europe Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
- Table 60 Europe Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
- Table 61 Europe Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
- Table 62 Europe Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 63 Europe Surrogacy Market Outlook, By End User (2021-2030) ($MN)
- Table 64 Europe Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 65 Europe Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
- Table 66 Europe Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 67 Asia Pacific Surrogacy Market Outlook, By Country (2021-2030) ($MN)
- Table 68 Asia Pacific Surrogacy Market Outlook, By Type (2021-2030) ($MN)
- Table 69 Asia Pacific Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
- Table 70 Asia Pacific Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
- Table 71 Asia Pacific Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
- Table 72 Asia Pacific Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
- Table 73 Asia Pacific Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
- Table 74 Asia Pacific Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
- Table 75 Asia Pacific Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
- Table 76 Asia Pacific Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
- Table 77 Asia Pacific Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
- Table 78 Asia Pacific Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
- Table 79 Asia Pacific Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
- Table 80 Asia Pacific Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
- Table 81 Asia Pacific Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
- Table 82 Asia Pacific Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
- Table 83 Asia Pacific Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
- Table 84 Asia Pacific Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 85 Asia Pacific Surrogacy Market Outlook, By End User (2021-2030) ($MN)
- Table 86 Asia Pacific Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 87 Asia Pacific Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
- Table 88 Asia Pacific Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 89 South America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
- Table 90 South America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
- Table 91 South America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
- Table 92 South America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
- Table 93 South America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
- Table 94 South America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
- Table 95 South America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
- Table 96 South America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
- Table 97 South America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
- Table 98 South America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
- Table 99 South America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
- Table 100 South America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
- Table 101 South America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
- Table 102 South America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
- Table 103 South America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
- Table 104 South America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
- Table 105 South America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
- Table 106 South America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 107 South America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
- Table 108 South America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 109 South America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
- Table 110 South America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 111 Middle East & Africa Surrogacy Market Outlook, By Country (2021-2030) ($MN)
- Table 112 Middle East & Africa Surrogacy Market Outlook, By Type (2021-2030) ($MN)
- Table 113 Middle East & Africa Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
- Table 114 Middle East & Africa Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
- Table 115 Middle East & Africa Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
- Table 116 Middle East & Africa Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
- Table 117 Middle East & Africa Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
- Table 118 Middle East & Africa Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
- Table 119 Middle East & Africa Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
- Table 120 Middle East & Africa Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
- Table 121 Middle East & Africa Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
- Table 122 Middle East & Africa Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
- Table 123 Middle East & Africa Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
- Table 124 Middle East & Africa Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
- Table 125 Middle East & Africa Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
- Table 126 Middle East & Africa Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
- Table 127 Middle East & Africa Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
- Table 128 Middle East & Africa Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
- Table 129 Middle East & Africa Surrogacy Market Outlook, By End User (2021-2030) ($MN)
- Table 130 Middle East & Africa Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 131 Middle East & Africa Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
- Table 132 Middle East & Africa Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
